 CRANBURY, N.J., Sept. 15, 2021 PRNewswire -- Palatin Technologies, Inc. NYSE American: PTN, a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor systems, today announced a featured speaker presentation and two poster presentations at the upcoming TIDES USA hybrid conference in Boston, Massachusetts on September 20-23, 2021. 